Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The histamine receptor H2 is a member of the rhodopsin-like family of G protein-coupled receptors (GPCRs). It is an integral membrane protein that plays a central role in mediating the physiological effects of histamine, particularly in stimulating gastric acid secretion. It couples primarily to the Gs alpha subunit, leading to activation of adenylate cyclase and increased cyclic AMP (cAMP) production.
H2 receptor antagonists competitively block the binding of histamine to H2 receptors on parietal cells, reducing gastric acid secretion.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine Receptor H2 Subtype.